Ellevest, Inc. Horizon Therapeutics Public LTD CO Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$107.32 - $113.5 $1,609 - $1,702	15 New	15 $1,000
Q2 2022 Jul 18, 2022	SELL	$79.4 - $116.36 $25,884 - $37,933	-326 Reduced 44.54%	406 $32,000
Q1 2022 Apr 19, 2022	BUY	$86.42 - $109.81 $38,197 - $48,536	442 Added 152.41%	732 $77,000
Q4 2021 Jan 24, 2022	BUY	$98.56 - $119.91 $15,868 - $19,305	161 Added 124.81%	290 $31,000
Q3 2021 Oct 19, 2021	BUY	$91.91 - $110.37 $11,856 - $14,237	129 New	129 $14,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.